Homotypic neutralizing antibody responses exceed heterotypic responses to Rotarix in Bangladeshi infants
In a randomized phase 4 trial of Bangladeshi infants, the Rotarix vaccine induced significantly stronger homotypic neutralizing antibody responses against G1P[8] strains compared to heterotypic responses against G2P[4] strains, particularly among those who seroconverted for IgA.